In addition, there are reports that PON1 enzyme activity is lower in cancer patients compared to healthy controls in various cancer types (lung, breast, gastrointestinal, etc.), which might reflect a reduced antioxidant defense [57]. The gene discussed is PON1; the disease is cancer.